1.Clinical Comparison of Automated Peritoneal Dialysis with Continuous Ambulatory Peritoneal Dialysis.
Jinhee CHO ; Sukyong YU ; Inwhee PARK ; Heungsoo KIM ; Gyu Tae SHIN
Korean Journal of Nephrology 2010;29(4):482-488
PURPOSE: Automated peritoneal dialysis (APD) is increasingly used due to freedom from daytime exchanges and flexibility of prescription. In this study, we compared APD with continuous ambulatory peritoneal dialysis (CAPD) to assess the influence of mode of PD on various measures of clinical performance. METHODS: We followed 26 APD patients prospectively over a 12-month period and compared them with 16 CAPD patients in whom examinations of dialysis dose and residual renal function (RRF) at least twice during the 1st one year after dialysis were done. Weekly Kt/V urea (Kt/V) and standard creatinine clearance (SCCr) of PD, and RRF (24hr urine creatinine clearance) were measured at 1st month, 6th month and 12th month after start of dialysis. In addition, serial biochemical tests were analyzed every three months during this period. RESULTS: No statistically significant differences in baseline characteristics, RRF, SCCr and Kt/V were observed between APD and CAPD patients. Serum concentrations of bicarbonate, hemoglobin, and calcium tended to be higher in the APD group and actually serum bicarbonate levels at 9 months, calcium levels at 12 months and hemoglobin levels at 6 and 9 months were significantly higher in APD patients (p<0.05). There was no significant difference in serum sodium concentrations and peritonitis rate between the two groups. CONCLUSION: No significant differences were observed between APD and CAPD in Kt/V, SCCr and RRF for one year after start of PD. APD, however, may be advantageous in improving several biochemical markers such as blood levels of hemoglobin, bicarbonate, and calcium compared to CAPD.
Biochemistry
;
Biomarkers
;
Calcium
;
Creatinine
;
Dialysis
;
Diphosphonates
;
Freedom
;
Hemoglobins
;
Humans
;
Peritoneal Dialysis
;
Peritoneal Dialysis, Continuous Ambulatory
;
Peritonitis
;
Pliability
;
Prescriptions
;
Prospective Studies
;
Sodium
;
Urea
2.A Case of a Kidney Transplant Recipient with Pulmonary Cytomegalovirus and Nocardia Coinfection with Cytomegalovirus Nephropathy.
Inwhee PARK ; Hyunee YIM ; Lim Seung KWAN ; Sukyong YU ; Jinhee CHO ; Heungsoo KIM ; Gyu Tae SHIN
Korean Journal of Nephrology 2009;28(2):161-165
This is the first reported case of a kidney transplant patient in Korea who developed cytomegalovirus and Nocardia pulmonary coinfection simultaneously with cytomegalovirus nephropathy. The patient had a history of end stage renal disease on peritoneal dialysis, diabetes mellitus and pulmonary tuberculosis. He underwent unrelated living kidney transplantation in China. About 5 months after transplantation, he developed high fever and rising serum creatinine for which he was admitted to hospital. Chest CT revealed consolidation in the left upper lung field and lung biopsy showed CMV infected bronchiolitis obliterans with organizing pneumonia. Culture of lung biopsy tissue grew Nocardia farcinica. In addition, he was found to have CMV infection in kidney tissue with positive CMV antigen assay of blood. This case emphasizes that CMV infection, through its effect on systemic immunity, may increase the risk of other opportunistic infection.
Biopsy
;
Bronchiolitis Obliterans
;
China
;
Coinfection
;
Creatinine
;
Cytomegalovirus
;
Diabetes Mellitus
;
Fever
;
Humans
;
Kidney
;
Kidney Failure, Chronic
;
Kidney Transplantation
;
Korea
;
Lung
;
Nocardia
;
Opportunistic Infections
;
Peritoneal Dialysis
;
Pneumonia
;
Thorax
;
Transplants
;
Tuberculosis, Pulmonary
3.Changes of Parathyroid Hormone and Vitamin D Metabolites According to Estimated Glomerular Filtration Rate in Chronic Kidney Disease Patients.
Sukyong YU ; Jinhee CHO ; Namkyu LIM ; Myounghee LEE ; Jinsun PARK ; Inwhee PARK ; Gyutae SHIN ; Heungsoo KIM
Korean Journal of Nephrology 2008;27(1):28-37
PURPOSE: Disturbances of mineral metabolism are common during the course of chronic kidney disease (CKD) and may lead to serious and debilitating complications unless properly treated. The purpose of this study is to quantify the prevalence of secondary hyperparathyroidism and vitamin D deficiency in non-dialysed chronic kidney disease 3, 4, and 5 in Korea. METHODS: This study included patients who had documented eGFR<60 mL/min/1.73m2 and non-dialysed and had not received any vitamin D compounds. eGFR was calculated by simplified MDRD (Modification of Diet in Renal Disease study) equation. Blood samples were collected for serum creatinine, calcium, phosphate, intact PTH and vitamin D metabolites between May 2006 and April 2007. RESULTS: According to K/DOQI guideline, the prevalence of hyperparathyroidism was 46.9% (15/32) in stage 3 (iPTH>70 pg/mL),45.9% (17/37) in stage 4 (iPTH>110 pg/mL) and 20.5% (9/44) in stage 5 patients (iPTH>300 pg/mL). The prevalence of 25-hydroxyvitamin D deficiency (25(OH)D3<15 ng/mL) was 86.2% (25/29) in stage 3, 75.7% (28/37) in stage 4 and 88.4% (38/43) in stage 5. There was a negative correlation between eGFR and intact PTH (r=-0.531, p=0.000) and a positive correlation between eGFR and 1,25-dihydroxyvitamin D (r=0.587, p=0.000). Conclusions: So far as non-dialysed CKD patients in Korea are concerned, quantification of the prevalence of abnormality of intact PTH and vitamin D deficiency has been described in this study. More research should be conducted in the future in a prospective, multi-center community cohort study, of which subjects include the early stages like CKD 1 and 2.
Calcium
;
Cohort Studies
;
Creatinine
;
Diet
;
Glomerular Filtration Rate
;
Humans
;
Hyperparathyroidism
;
Hyperparathyroidism, Secondary
;
Kidney Failure, Chronic
;
Korea
;
Parathyroid Hormone
;
Prevalence
;
Renal Insufficiency, Chronic
;
Vitamin D
;
Vitamin D Deficiency
;
Vitamins
4.Vancomycin Pharmacokinetics in Oliguric Patients Undergoing Continuous Venovenous Hemodialysis and Continuous Venovenous Hemodiafiltration.
Inwhee PARK ; Sun A LEE ; Seung Kwan LIM ; Sukyong YU ; Eun Jung JANG ; Eun Joon MOON ; Joo An HWANG ; Heungsoo KIM ; Gyu Tae SHIN
Korean Journal of Nephrology 2010;29(5):585-592
PURPOSE: Critically ill patients receiving continuous renal replacement therapy are susceptible to infection with methicillin-resistant bacteria, which require treatment with vancomycin. However, there are limited reports regarding vancomycin pharmacokinetics in the continuous venovenous hemodialysis (CVVHD) and continuous venovenous hemodiafiltration (CVVHDF). We performed this study to investigate the pharmacokinetics of vancomycin in oliguric patients receiving CVVHD and CVVHDF. METHODS: Data at steady-state obtained as part of our routine drug monitoring of vancomycin therapy in critically ill adult oliguric patients undergoing CVVHD or CVVHDF, retrospectively. Data were available for 35 cases of 23 patients assessed for 2 years. We analyzed the pharmacokinetic parameters of these cases. RESULTS: 8 cases on CVVHD and 27 cases on CVVHDF were available. The mean intensity of CVVHD was 17.7+/-4.9 mL/hour/kg and that of CVVHDF was 32.1+/-3.9 mL/hour/kg (p=0.000). The mean clearance of vancomycin was 16.4+/-3.8 mL/min in the CVVHD group and 21.6+/-5.1 mL/min in the CVVHDF group (P=0.007). The elimination of vancomycin correlated with the intensity of CVVHD and CVVHDF (CVVHD; r2=0.745, p=0.012, CVVHDF; r2=0.452, p=0.000). CONCLUSION: CVVHD and CVVHDF are effective for vancomycin elimination and there is a strong dependency of the vancomycin removal on the intensity of continuous renal replacement therapy. Strategies for individualization of vancomycin therapy in patients receiving CVVHD and CVVHDF are proposed.
Adult
;
Bacteria
;
Critical Illness
;
Dependency (Psychology)
;
Drug Monitoring
;
Hemodiafiltration
;
Humans
;
Methicillin Resistance
;
Renal Dialysis
;
Renal Replacement Therapy
;
Retrospective Studies
;
Vancomycin
5.Association of Interleukin-12 Gene Polymorphism with Persistence of Hepatitis B Virus Infection and Hepatocellular Carcinoma.
Jin Sun PARK ; Jae Youn CHEONG ; Joon Koo KANG ; Jin Hee CHO ; Sukyong YU ; Hyoung Doo SHIN ; Byung Lae PARK ; Sung Won CHO
The Korean Journal of Gastroenterology 2007;50(5):313-318
BACKGROUND/AIMS: Infection with hepatitis B virus (HBV) may result in various conditions. Natural course of HBV infection is influenced by various host immune factors and cytokines play a crucial role in host immune defense. This study was undertaken to investigate the association between HBV persistence and development of hepatocelluar carcinoma (HCC) and single nucleotide polymorphisms (SNPs) of interleukin (IL)-12A. METHODS: Between March 2002 and December 2004, seven hundred thirty Korean patients with HBV infection and 320 healthy individuals who recovered from HBV infection were enrolled. We assessed polymorphisms and haplotype in IL-12A, and the genotype distributions of the HBV clearance and persistence groups were compared in order to investigate the association between HBV persistence and SNPs of IL-12A. Moreover, the genotypic distributions between patients with HCC and without HCC were compared to investigate the association between the development of HCC and SNPs of IL-12A. RESULTS: We asssesed the SNPs of IL-12A at position +6400, +6624 and +7003. On the basis of logistic regression analysis, no statistically significant association with HBV persistence was observed with IL-12A exon 7 +6400, +6624, 3' UTR +7003 SNP and haplotype of IL-12A +6400/+6624/+7003. Furthermore, no statistically significant association of HCC development with IL-12A exon 7 +6400, +6624, 3' UTR +7003 SNP and haplotype of IL-12A +6400/+6624/+7003 was observed. CONCLUSIONS: These results suggest that SNPs and haplotype of IL-12A are not associated with HBV persistence and development of HCC. Further studies are needed to identify the host genetic factors in immune defense including cytokine gene polymorphisms of both IL-12A and IL-12B.
Adult
;
Aged
;
Carcinoma, Hepatocellular/etiology/*genetics/virology
;
Female
;
Genetic Predisposition to Disease
;
Genotype
;
Haplotypes
;
Hepatitis B/complications/*genetics
;
Hepatitis B virus/isolation & purification
;
Hepatitis B, Chronic/complications/*genetics
;
Heterozygote
;
Humans
;
Interleukin-12 Subunit p35/*genetics
;
Liver Neoplasms/etiology/*genetics/virology
;
Male
;
Middle Aged
;
Polymorphism, Single Nucleotide
;
Retrospective Studies
;
Risk Factors